<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>14572369</identifier>
<setSpec>0025-7753</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Fraile, Manuel</dc:author>
<dc:author>Castellà, Eva</dc:author>
<dc:author>Salavert, Agustí</dc:author>
<dc:author>Riba, Joaquín</dc:author>
<dc:author>Alastrué, Antoni</dc:author>
<dc:author>Solá, Montserrat</dc:author>
<dc:author>Vallejos, Virginia</dc:author>
<dc:author>Anmella, Joaquín</dc:author>
<dc:author>Bara, Javier</dc:author>
<dc:description xml:lang="en">BACKGROUND AND OBJECTIVE Sentinel node (SN) biopsy represents an alternative to full lymph node dissection in the surgical treatment of several malignant tumors. PATIENTS AND METHOD Prospective study of 32 consecutive patients with clinically node-negative oral cancer comparing SN biopsy results with standard neck dissection. RESULTS An effective SN localization was achieved in 31 patients (97%) and a complete agreement with neck dissection was observed: 16 were true negative and 15 were true positive. In 11 out of the 15 positive cases, the SN was the only node containing metastasis (73%). CONCLUSION SN biopsy predicts the subclinical lymph node status in oral cancer patients.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:date>2003 Oct 11 </dc:date>
<dc:title xml:lang="es">Biopsia selectiva del ganglio centinela en pacientes con carcinoma oral: estudio piloto.</dc:title>
<dc:title xml:lang="en">[Sentinel node biopsy in patients with oral cancer: a pilot study].</dc:title>
<dc:publisher>Medicina clinica</dc:publisher>
</metadata>
</record>
</pubmed-document>
